GlassScriptPhysician profile
Kamran A Khan
NPI 1053339416
$4,654.66
in general payments reported to CMS, 2019-2025
42 companies · $617 in 2025
The $617 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $557 · 2021: $810 · 2022: $854 · 2023: $617 · 2024: $675 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,909.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $789.24 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $403.63 | 2019-2025 | Repatha, Otezla, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $397.06 | 2021-2024 | |
| Novo Nordisk INC | $380.37 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $298.05 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $277.21 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $196.77 | 2020-2023 | Verquvo, Steglujan, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.94 | 2019-2025 | Jardiance |
| Edwards Lifesciences Corporation | $134.85 | 2025 | Pascal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.51 | 2019-2023 | Xifaxan |
| Lilly USA, LLC | $133.35 | 2021-2025 | Mounjaro, Zepbound |
| Eisai INC. | $90.55 | 2020-2021 | |
| Exact Sciences Corporation | $88.69 | 2023-2025 | Cologuard Collection Kit |
| Insmed, INC. | $87.78 | 2024 | Arikayce |
| Pfizer INC. | $84.97 | 2020-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamran Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.